Pediatric Anesthesia Practice Questions

Q: Which of the following anesthetic induction agents should be avoided in a 4-year-old boy with temporal lobe epilepsy?

Ketamine. **Explanation:** The correct answer is **Ketamine**. **1. Why Ketamine is avoided:** Ketamine is a phencyclidine derivative that acts as an NMDA receptor antagonist. While it provides excellent analgesia and dissociation, it is known to stimulate the central nervous system. In patients with a history of epilepsy, Ketamine can lower the seizure threshold and induce **epileptiform activity** on an EEG. Specifically, it can trigger seizure foci in the cortical and subcortical areas, making it contraindicated (or used with extreme caution) in patients with poorly controlled epilepsy or temporal lobe lesions. **2. Analysis of Incorrect Options:** * **Thiopental:** This is a barbiturate and is actually considered an **anticonvulsant**. It is often used to terminate status epilepticus. It increases the seizure threshold and is safe (even protective) for patients with epilepsy. * **Halothane:** While potent inhalational agents can occasionally show EEG changes at very high concentrations, Halothane does not have significant pro-convulsant properties. It is generally safe for induction in epileptic children, though Sevoflurane is more commonly used in modern practice. **3. NEET-PG High-Yield Pearls:** * **Pro-convulsant Agents:** Ketamine, Methohexital (often used to *induce* seizures during ECT), and Etomidate (can activate seizure foci). * **Meperidine (Pethidine):** Its metabolite, **normeperidine**, is a potent CNS stimulant and can cause seizures, especially in renal failure. * **Sevoflurane Paradox:** At high concentrations (>2 MAC) and with hypocapnia, Sevoflurane can show epileptiform patterns on EEG, but it is clinically used safely in most pediatric cases. * **Drug of Choice for Status Epilepticus (Anesthesia):** Thiopental or Propofol.

Q: What is the incidence of malignant hyperthermia in pediatric patients?

1 in 15,000. **Explanation:** **Malignant Hyperthermia (MH)** is a rare but life-threatening pharmacogenetic hypermetabolic disorder of skeletal muscle, triggered primarily by volatile anesthetic gases (e.g., Halothane, Sevoflurane) and the depolarizing muscle relaxant Succinylcholine. 1. **Why Option A is Correct:** The incidence of MH varies significantly between adults and children. In the **pediatric population**, the incidence is approximately **1 in 15,000** administrations of anesthetic triggers. This is notably higher than in the adult population, where the incidence is estimated to be around 1 in 40,000 to 1 in 50,000. The higher frequency in children is attributed to a higher prevalence of undiagnosed myopathies and the frequent use of triggering agents in pediatric procedures. 2. **Why Other Options are Incorrect:** * **Options B, C, and D:** These values (1:20,000 to 1:35,000) represent intermediate figures that do not align with standard epidemiological data for children. While some older texts might vary slightly, **1:15,000** is the classic "high-yield" figure taught for pediatric anesthesia in competitive exams like NEET-PG. **High-Yield Clinical Pearls for NEET-PG:** * **Pathophysiology:** Caused by a mutation in the **RYR1 gene** (Ryanodine Receptor), leading to uncontrolled calcium release from the sarcoplasmic reticulum. * **Earliest Sign:** An increase in **End-Tidal CO2 (ETCO2)** is the earliest and most sensitive clinical sign. * **Masseter Muscle Rigidity (MMR):** If seen after Succinylcholine, it is a strong warning sign of MH. * **Drug of Choice:** **Dantrolene** (Mechanism: Inhibits calcium release from the RYR1 receptor). * **Safe Agents:** Nitrous oxide, Propofol, Etomidate, Ketamine, and all local anesthetics.

Q: What is the inhalational agent of choice for pediatric anesthesia in a child with congenital heart disease?

Sevoflurane. **Explanation:** **Sevoflurane** is the inhalational agent of choice for pediatric anesthesia, including children with congenital heart disease (CHD), primarily due to its **excellent hemodynamic stability** and **non-pungent nature**. 1. **Why Sevoflurane is Correct:** * **Smooth Induction:** It has a low blood-gas solubility coefficient (0.65), allowing for rapid induction and recovery. Its non-irritating odor makes it ideal for mask induction in children. * **Hemodynamic Profile:** Unlike other agents, Sevoflurane maintains heart rate and cardiac output well. It causes minimal sensitization of the myocardium to catecholamines, reducing the risk of arrhythmias—a critical factor in CHD patients. * **Autonomic Stability:** It preserves the baroreceptor reflex better than halothane. 2. **Why Other Options are Incorrect:** * **Halothane:** Historically used for pediatric induction, it is now avoided because it causes significant myocardial depression and sensitizes the heart to catecholamines, leading to **halothane-induced arrhythmias**. It also carries a risk of halothane hepatitis. * **Isoflurane:** While hemodynamically stable, it is highly **pungent**. This causes airway irritation, breath-holding, coughing, and laryngospasm during mask induction in children. * **Enflurane:** It is rarely used today due to its potential to lower the seizure threshold (epileptogenic) and significant myocardial depression. **High-Yield Clinical Pearls for NEET-PG:** * **Agent of choice for Induction:** Sevoflurane (due to lack of pungency). * **Agent of choice for Maintenance:** Isoflurane (due to cost-effectiveness and stability). * **Fastest Induction/Recovery:** Desflurane (but too pungent for pediatric mask induction). * **Avoid in CHD:** High-dose Halothane should be avoided due to the risk of bradycardia and decreased cardiac output.

Q: A six-year-old boy is scheduled for examination of the eye under anesthesia. The father reports that for the past six months, the child has been developing progressive weakness of both legs. His elder sibling died at the age of 14 years. Which drug should be definitely avoided during the anesthetic management?

Succinylcholine. **Explanation** **Diagnosis and Rationale** The clinical presentation—a young boy with progressive leg weakness and a family history of early death in a sibling—is highly suggestive of **Duchenne Muscular Dystrophy (DMD)**. In patients with underlying myopathies or muscular dystrophies, **Succinylcholine** must be strictly avoided. Succinylcholine is a depolarizing neuromuscular blocker that causes prolonged depolarization of the sarcolemma. In diseased muscle, this leads to a massive, uncontrolled release of intracellular potassium into the extracellular space (**Hyperkalemia**). This can result in sudden cardiac arrest, often refractory to resuscitation. Furthermore, DMD patients are at a higher risk of developing **Rhabdomyolysis** and are traditionally considered at risk for Malignant Hyperthermia-like reactions. **Analysis of Incorrect Options** * **B. Thiopentone:** An intravenous induction agent. While it must be used cautiously due to potential myocardial depression in DMD, it is not contraindicated. * **C. Nitrous oxide:** An inhalational analgesic/anesthetic gas that is safe to use in patients with muscular dystrophy. * **D. Vecuronium:** A non-depolarizing neuromuscular blocker (NDNMB). NDNMBs are safe to use in DMD, although their effects may be prolonged, requiring careful titration and monitoring. **Clinical Pearls for NEET-PG** * **Black Box Warning:** The FDA has a black box warning for Succinylcholine in children due to the risk of hyperkalemic cardiac arrest from undiagnosed myopathies. * **DMD Inheritance:** X-linked recessive; symptoms usually appear between ages 3–5. * **Management of Hyperkalemia:** If arrest occurs after Succinylcholine, treat immediately with **Calcium Gluconate/Chloride**, insulin/glucose, and bicarbonate. * **Inhalational Agents:** Potent volatile anesthetics (like Sevoflurane) should also be used with caution in DMD due to the risk of Rhabdomyolysis.

Q: All of the following are cardiac effects of succinylcholine when administered in a 12-year-old child, EXCEPT:

Second dose will cause profound tachycardia.. Succinylcholine is a depolarizing neuromuscular blocker that acts as an analog of acetylcholine. Its cardiac effects are complex because it stimulates all cholinergic receptors, including nicotinic receptors at autonomic ganglia and muscarinic receptors in the heart. **Explanation of the Correct Option:** * **Option B (Correct):** In children, the predominant response to succinylcholine (especially a second dose) is **profound bradycardia**, not tachycardia. This occurs because the metabolite of succinylcholine, succinylmonocholine, sensitizes the muscarinic receptors in the sinoatrial (SA) node. To prevent this life-threatening bradycardia or asystole, atropine is often administered prophylactically in pediatric patients. **Analysis of Incorrect Options:** * **Option A:** This is a true statement. Succinylcholine works by binding to nicotinic cholinergic receptors at the motor endplate, causing prolonged depolarization. * **Option C:** This is true. Succinylcholine is non-selective and stimulates both nicotinic (ganglia/NMJ) and muscarinic (heart/glands) receptors throughout the body. * **Option D:** This is true. While low doses or repeat doses typically cause bradycardia, very high doses can stimulate the sympathetic ganglia and adrenal medulla, leading to an increase in heart rate and contractility (tachycardia and hypertension). **High-Yield Clinical Pearls for NEET-PG:** * **Black Box Warning:** Succinylcholine is contraindicated for routine intubation in children due to the risk of hyperkalemic cardiac arrest (unrecognized Duchenne Muscular Dystrophy). * **Pre-treatment:** Always co-administer **Atropine (0.02 mg/kg)** in children to counteract the vagomimetic effects. * **Phase II Block:** Prolonged exposure or high doses can lead to a Phase II block, which resembles a non-depolarizing block.

Q: An 8-year-old boy, weighing 30kg, is undergoing resection of a Wilms tumor. His hemoglobin is 12g/dL. If the threshold for transfusion is 8g/dL, what is the allowable blood loss?

840ml. ### Explanation The calculation of **Allowable Blood Loss (ABL)** is a critical skill in pediatric anesthesia to prevent hemodilution-induced anemia and ensure timely transfusion. **1. The Calculation (Why B is correct):** To calculate ABL, we use the standard formula: $$ABL = \frac{EBV \times (H_i - H_f)}{H_i}$$ *Where: EBV = Estimated Blood Volume; $H_i$ = Initial Hemoglobin; $H_f$ = Final (Target) Hemoglobin.* * **Step 1: Determine EBV.** For a child (older than 1 year), the average EBV is **70 ml/kg**. * $EBV = 30\text{ kg} \times 70\text{ ml/kg} = 2100\text{ ml}$. * **Step 2: Apply the formula.** * $ABL = \frac{2100 \times (12 - 8)}{12}$ * $ABL = \frac{2100 \times 4}{12}$ * $ABL = \frac{8400}{12} = \mathbf{840\text{ ml}}$. **2. Why other options are incorrect:** * **A (820ml):** This value would result if a lower EBV (approx. 68 ml/kg) was used, which is not the standard teaching for an 8-year-old. * **C & D (860ml & 880ml):** These values would result from using higher EBV constants (72–74 ml/kg), which are more characteristic of infants rather than school-aged children. **3. Clinical Pearls for NEET-PG:** * **EBV Variations by Age:** * Premature Neonates: 90–100 ml/kg * Full-term Neonates: 80–90 ml/kg * Infants (3 mo – 1 year): 75–80 ml/kg * **Children (>1 year): 70–75 ml/kg** (Use 70 for calculations unless specified) * Adult Males: 70 ml/kg; Adult Females: 65 ml/kg * **Wilms Tumor:** Often involves significant blood loss due to its vascular nature and proximity to major vessels (IVC). * **Transfusion Trigger:** While 8 g/dL is used here, the clinical decision to transfuse also depends on the rate of bleeding and hemodynamic stability.

Q: The Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) for rating postoperative pain in children includes all of the following components except?

Oxygen saturation. **Explanation:** The **Children's Hospital of Eastern Ontario Pain Scale (CHEOPS)** is a behavioral scale used to assess postoperative pain in children, typically aged 1 to 7 years. It relies entirely on **behavioral observations** rather than physiological parameters. **Why Oxygen Saturation is the Correct Answer:** Oxygen saturation ($SpO_2$) is a **physiological parameter**, not a behavioral one. While physiological changes (tachycardia, hypertension, or desaturation) can occur due to pain, they are non-specific and can be influenced by anesthesia, respiratory distress, or anxiety. Therefore, $SpO_2$ is **not** a component of the CHEOPS scale. **Analysis of Incorrect Options (Components of CHEOPS):** The CHEOPS scale evaluates six specific behavioral categories, each scored from 0–2 or 1–3 (Total score range: 4–13): * **Cry (Option A):** Assesses if the child is not crying, moaning, or screaming. * **Touch (Option B):** Evaluates the child’s reaction to the wound site (e.g., not touching, reaching, or grabbing). * **Torso (Option C):** Observes body posture (e.g., neutral, shifting, tense, or shivering). * *Other components include:* **Facial Expression** (smiling, neutral, or grimacing), **Verbalization** (positive, neutral, or complaining), and **Legs** (neutral, kicking, or drawn up). **High-Yield Clinical Pearls for NEET-PG:** * **CHEOPS Cut-off:** A score of **$\geq$ 6** is generally considered indicative of significant pain requiring intervention. * **FLACC Scale:** Another high-yield behavioral scale (Face, Legs, Activity, Cry, Consolability) used for infants and non-verbal children. * **Self-Reporting:** The **Wong-Baker FACES Scale** is the gold standard for children who can self-report (usually $>3$ years). * **Physiological Scales:** Scales like **CRIES** (used in neonates) *do* include physiological parameters like $SpO_2$ and Heart Rate, unlike CHEOPS.

Question 1

Which of the following anesthetic induction agents should be avoided in a 4-year-old boy with temporal lobe epilepsy?

Accepted Answer

Ketamine

Answer

Thiopental

Answer

Halothane

Answer

All of the above

Question 2

A five-year-old child is scheduled for strabismus surgery. The anesthesiologist monitors the pulse while the surgeon grasps the medial rectus muscle. What is the primary reason for this monitoring?

Accepted Answer

To detect Aschner's reflex

Answer

To assess the depth of anesthesia

Answer

To rule out ventricular dysrhythmias

Answer

To detect hypotension

Question 3

What is the incidence of malignant hyperthermia in pediatric patients?

Accepted Answer

1 in 15,000

Answer

1 in 20,000

Answer

1 in 25,000

Answer

1 in 35,000

Question 4

An 8-year-old child presents with testicular torsion and has not eaten for 6 hours. The surgeon wishes to operate immediately. What is the appropriate anesthetic management regarding fasting and urgency?

Accepted Answer

Take the child to the operating room immediately, deem it emergent, and perform rapid-sequence intubation.

Answer

Wait for 2 more hours, deem it urgent, and perform rapid-sequence intubation.

Answer

The child is adequately fasted; consider elective intubation.

Answer

Wait for 2 hours and consider elective intubation.

Question 5

Regarding neonatal circumcision, which one of the following statements is true?

Accepted Answer

It should be done under local anesthesia only.

Answer

It should be done without anesthesia, as it is hazardous to give anesthesia.

Answer

It should be done without anesthesia, as neonates do not perceive pain as adults.

Answer

General anesthesia should be given to neonates for circumcision as they also feel pain as adults.

Question 6

What is the inhalational agent of choice for pediatric anesthesia in a child with congenital heart disease?

Accepted Answer

Sevoflurane

Answer

Isoflurane

Answer

Halothane

Answer

Enflurane

Question 7

A six-year-old boy is scheduled for examination of the eye under anesthesia. The father reports that for the past six months, the child has been developing progressive weakness of both legs. His elder sibling died at the age of 14 years. Which drug should be definitely avoided during the anesthetic management?

Accepted Answer

Succinylcholine

Answer

Thiopentone

Answer

Nitrous oxide

Answer

Vecuronium

Question 8

All of the following are cardiac effects of succinylcholine when administered in a 12-year-old child, EXCEPT:

Accepted Answer

Second dose will cause profound tachycardia.

Answer

Stimulates nicotinic cholinergic receptors at the neuromuscular junction.

Answer

Stimulates all acetylcholine receptors.

Answer

Higher doses increase heart rate and contractility of the heart.

Question 9

An 8-year-old boy, weighing 30kg, is undergoing resection of a Wilms tumor. His hemoglobin is 12g/dL. If the threshold for transfusion is 8g/dL, what is the allowable blood loss?

Accepted Answer

840ml

Answer

820ml

Answer

860ml

Answer

880ml

Question 10

The Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) for rating postoperative pain in children includes all of the following components except?

Accepted Answer

Oxygen saturation

Answer

Cry

Answer

Touch

Answer

Torso

Pediatric Anesthesia — MCQs

Pediatric Anesthesia — MCQs

On this page

Practice by Chapter

Want unlimited practice?